SFDA Advises Continued Use of Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARBs) in Patients with COVID-19

SFDA Advises Continued Use of Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARBs) in Patients with COVID-19

2020-04-14

SFDA Advises Continued Use of Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARBs) in Patients with COVID-19

Precautions